Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/12/1995 | WO1995025509A3 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
10/12/1995 | WO1995022639A3 Process for producing coated polymer microparticles |
10/12/1995 | DE4411993A1 Tasty balls for pets to chew for combatting bad breath |
10/12/1995 | CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage |
10/12/1995 | CA2186863A1 Heterofunctional, mucoadhesive dosage form |
10/12/1995 | CA2186785A1 Process for producing sustained-release tablets and enteric tablets |
10/12/1995 | CA2186734A1 Ophthalmic composition with decreased viscosity |
10/12/1995 | CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists |
10/12/1995 | CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
10/12/1995 | CA2186370A1 Use of mcp-1 for inducing ripening of the cervix |
10/12/1995 | CA2184261A1 Alphavirus cdna vectors |
10/11/1995 | EP0676408A1 Process for the production of antibacterial agents and their use |
10/11/1995 | EP0676204A1 Combinations of an organic nitrate and a salicylate |
10/11/1995 | EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide |
10/11/1995 | EP0675720A1 Transdermal, multiphasic hormone replacement therapy |
10/11/1995 | EP0675711A1 Atovaquone pharmaceutical compositions |
10/11/1995 | EP0675710A1 Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
10/11/1995 | EP0675709A1 Freeze-dried emulsion containing an active substance |
10/11/1995 | EP0675686A1 Granular agent for ruminants. |
10/11/1995 | EP0665759A4 Dry powder inhaler. |
10/11/1995 | EP0596908B1 Mouth-hygiene agent containing hydrogen peroxide stabilized by colloidal silver |
10/11/1995 | EP0559682B1 Topical composition |
10/11/1995 | CN1109785A Organopolysiloxane composition of gel-like apperarance, containing no gelling agent, which may be used in cosmetics and dermatology |
10/11/1995 | CN1109781A Eye drops-type insulin liquor and producing process thereof |
10/11/1995 | CN1109779A Once-granulating process of ginseng and bupleurum root particles for curing hepatitis |
10/11/1995 | CN1109771A Ointment for curing burn and scald and producing process thereof |
10/11/1995 | CN1109770A Borneol-toad venom ointment for repercussion and analgesic, Chinese-medical prescription thereof and preparing process |
10/11/1995 | CN1109755A Antiviral, Highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3',-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate |
10/11/1995 | CN1109754A Argatroban consentrated aqueous solution |
10/11/1995 | CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
10/11/1995 | CN1109748A Rapamycin formulation for IV injection |
10/11/1995 | CN1109747A Rapamycin formulation for IV injection |
10/11/1995 | CN1109746A Rapamycin formulations for oral administration |
10/11/1995 | CN1109745A Ibuprofen-containing solid composition |
10/11/1995 | CN1109744A Soft viaminate capsule and producing process thereof |
10/11/1995 | CN1109743A Controlled release-initiation and controlled release-rate pharmaceutical composition |
10/11/1995 | CN1109742A Toothpaste for health of cardio-cerebral blood vessel |
10/11/1995 | CN1109741A Cosmatic and/or dermal composition containing salicylic acid |
10/11/1995 | CN1029967C New xanthine derivatives |
10/11/1995 | CN1029935C Pharmaceutical preparation and process for same |
10/10/1995 | US5457117 Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B][2-(piperidin-1-yl)ethoxyphenylimethanone hydrochloride |
10/10/1995 | US5457093 Gel formulations containing growth factors |
10/10/1995 | US5456985 Microcapsules of oily liquid |
10/10/1995 | US5456941 Process for preparing biodegradable water-resistant film and method for rendering biodegradable article water-resistant |
10/10/1995 | US5456932 Adding fructose to reduce heat needed to create flash flow conditions |
10/10/1995 | US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution |
10/10/1995 | US5456923 Method of manufacturing solid dispersion |
10/10/1995 | US5456922 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
10/10/1995 | US5456921 Epichlorohydrin or dibromopropanol/2,3-/ used as crosslinker for amylose matrix as sustained release matrix |
10/10/1995 | US5456920 Uncoated tablets and method of producing the same |
10/10/1995 | US5456918 Ranitidine pharmaceutical compositions |
10/10/1995 | US5456917 Method for making a bioerodible material for the sustained release of a medicament and the material made from the method |
10/10/1995 | US5456915 Moisturizers containing 3-methyl-1,3-butanediol and 1,3-butanediol; higher moisturizing efficacy |
10/10/1995 | US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging |
10/10/1995 | US5456900 Low density microspheres and their use as contrast agents for computed tomography |
10/10/1995 | US5456746 Gelatin containing ester of fatty acid and glycerol; reduces cracking, chipping, leakage of capsules |
10/10/1995 | US5456745 Anion-active, and cation-active water soluble polymer, moisturizer, water, auxiliaries, active substance |
10/10/1995 | US5456679 Use for the pulsatile delivery of a beneficial agent |
10/10/1995 | US5456677 Method for oral spray administration of caffeine |
10/10/1995 | US5456247 Method for delivering drugs soluble in a vaporization vehicle |
10/10/1995 | CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
10/10/1995 | CA1337275C Aqueous based pharmaceutical coating composition for dosage forms |
10/10/1995 | CA1337274C Enteric film and preparation thereof |
10/10/1995 | CA1337273C Method for size separation of particles |
10/10/1995 | CA1337272C Drug adsorbates |
10/10/1995 | CA1337270C Multilayer plaster |
10/10/1995 | CA1337262C Time release protein |
10/10/1995 | CA1337235C Chemical reactions in reverse micelle systems |
10/06/1995 | CA2145968A1 Topical antipruritic composition |
10/05/1995 | WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
10/05/1995 | WO1995026376A2 Polymer microspheres and a method of production thereof |
10/05/1995 | WO1995026356A1 Novel cationic phospholipids for transfection |
10/05/1995 | WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
10/05/1995 | WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
10/05/1995 | WO1995026191A1 Injectable solutions of dirithromycin |
10/05/1995 | WO1995026186A1 Methods of administering n-substituted benzamides or phenothiazines |
10/05/1995 | WO1995026185A1 Liposome with increased retention volume |
10/05/1995 | WO1995026184A1 Process for producing a saponine foam, medical, cosmetic, germicide or parasiticide foaming agent, and use of the same |
10/05/1995 | WO1995026158A1 Method and apparatus for diagnosing erectile dysfunction |
10/05/1995 | WO1995026155A1 Pillowcase |
10/05/1995 | WO1995026134A1 Composition for inactivating irritants in fluids |
10/05/1995 | WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
10/05/1995 | DE4411557A1 Verfahren zur Herstellung von Mikroemulsionen A process for the preparation of microemulsions |
10/05/1995 | DE4410778A1 Verfahren zur Herstellung eines medizinisch, kosmetisch, keimabtötend oder parasitenabtötend wirkenden Mittels, sowie Mittel zur Durchführung des Verfahrens und Mittel hergestellt nach dem Verfahren sowie die Verwendung der hergestellten Mittel A method for producing a medical, cosmetic, germicidal or parasitenabtötend acting agent, and means for performing the method and means produced by the method and to the use of compositions prepared |
10/05/1995 | CA2186745A1 Liposome with increased retention volume |
10/05/1995 | CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
10/05/1995 | CA2182952A1 Methods of administering n-substituted benzamides or phenothiazines |
10/04/1995 | EP0674913A2 Non-occulusive adhesive patch for applying medication to the skin |
10/04/1995 | EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol |
10/04/1995 | EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen |
10/04/1995 | EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen |
10/04/1995 | EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
10/04/1995 | EP0674529A1 Lipid prodrugs for oral administration |
10/04/1995 | EP0674528A1 Cyclodextrin and polymer based drug delivery system |
10/04/1995 | EP0674525A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
10/04/1995 | EP0674524A1 Stable lyophilized pharmaceutical preparations g-csf |
10/04/1995 | EP0674523A1 Topical composition containing garlic oil |
10/04/1995 | EP0674522A1 Linseed mucilage |
10/04/1995 | EP0674520A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries |
10/04/1995 | EP0674518A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries |